MoneyWorks4Me

Syncom Formulations (India) informs about standalone unaudited financial results

23 Dec 2017 Evaluate

Syncom Formulations (India) has informed about submission of Revised Standalone Unaudited Financial Results along with Limited Review Report thereon by Statutory Auditors for Quarter/ Half-Year ended on 30th September, 2017 in accordance with Regulation 33 of the SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..